Supply of pharmaceutical specialties based on NITISINONE in capsules
About This Opportunity
Ted Belgium: Levering van farmaceutische specialiteiten op basis van. Supplies contract awarded, healthcare. Awarded to Arega Pharma BV (EUR 434K).
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Belgium, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Auto-translated from DutchThis tender, originating from Belgium and published via the Tenders Electronic Daily (TED) platform, seeks the supply of specialized pharmaceutical products. The procurement specifically concerns NITISINONE in capsule form, a critical medication used in the treatment of certain metabolic disorders. The contracting authority, managed by the Publications Office of the European Union, is looking to establish a reliable supply chain for this essential pharmaceutical.
This is a competitive procurement process for the supply of goods, with the primary objective being to secure high-quality NITISINONE capsules that meet stringent regulatory and efficacy standards. Typical requirements for such tenders often include detailed product specifications, proof of manufacturing compliance with Good Manufacturing Practices (GMP), and robust quality control measures. Bidders are expected to demonstrate their capacity to deliver consistently and reliably, adhering to strict timelines and storage conditions appropriate for pharmaceutical products. Furthermore, documentation regarding product registration, safety data, and pharmacovigilance will likely be a key component of the evaluation. The contracting authority aims to ensure the availability of this specialized medication to patients requiring it.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 5, 2026. Last refreshed 91 days ago. Original language: Dutch. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Belgium. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Arega Pharma BV. The award notice is archived on BidsFactory for transparency and market intelligence.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
Arega Pharma BV was awarded the contract for €434,268. The figure reflects the value disclosed by the contracting authority in the award notice.
Find tenders like this automatically
Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.